CN1168713C - 制备鼻病毒蛋白酶抑制剂的合成路线以及关键的中间体 - Google Patents
制备鼻病毒蛋白酶抑制剂的合成路线以及关键的中间体 Download PDFInfo
- Publication number
- CN1168713C CN1168713C CNB008118779A CN00811877A CN1168713C CN 1168713 C CN1168713 C CN 1168713C CN B008118779 A CNB008118779 A CN B008118779A CN 00811877 A CN00811877 A CN 00811877A CN 1168713 C CN1168713 C CN 1168713C
- Authority
- CN
- China
- Prior art keywords
- formula
- compound
- reaction
- compounds
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/24—Stationary reactors without moving elements inside
- B01J19/2415—Tubular reactors
- B01J19/2435—Loop-type reactors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/24—Stationary reactors without moving elements inside
- B01J19/2475—Membrane reactors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
- C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00049—Controlling or regulating processes
- B01J2219/00051—Controlling the temperature
- B01J2219/00074—Controlling the temperature by indirect heating or cooling employing heat exchange fluids
- B01J2219/00087—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor
- B01J2219/00099—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor the reactor being immersed in the heat exchange medium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00049—Controlling or regulating processes
- B01J2219/00051—Controlling the temperature
- B01J2219/00159—Controlling the temperature controlling multiple zones along the direction of flow, e.g. pre-heating and after-cooling
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15035899P | 1999-08-24 | 1999-08-24 | |
| US60/150,358 | 1999-08-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1374947A CN1374947A (zh) | 2002-10-16 |
| CN1168713C true CN1168713C (zh) | 2004-09-29 |
Family
ID=22534156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB008118779A Expired - Fee Related CN1168713C (zh) | 1999-08-24 | 2000-08-23 | 制备鼻病毒蛋白酶抑制剂的合成路线以及关键的中间体 |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1206450A1 (es) |
| JP (1) | JP2003507453A (es) |
| KR (1) | KR20020046283A (es) |
| CN (1) | CN1168713C (es) |
| AR (1) | AR025380A1 (es) |
| AU (1) | AU770221B2 (es) |
| BR (1) | BR0013306A (es) |
| CA (1) | CA2376452A1 (es) |
| CO (1) | CO5200782A1 (es) |
| CZ (1) | CZ2002632A3 (es) |
| HK (1) | HK1049336B (es) |
| HU (1) | HUP0203365A3 (es) |
| IL (1) | IL147674A0 (es) |
| MX (1) | MXPA02001944A (es) |
| PE (1) | PE20010517A1 (es) |
| PL (1) | PL353997A1 (es) |
| TW (1) | TWI245040B (es) |
| UY (1) | UY26307A1 (es) |
| WO (1) | WO2001014329A1 (es) |
| ZA (1) | ZA200200504B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1073672B1 (en) | 1998-04-30 | 2003-08-27 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds, their preparation and use |
| DK1206484T3 (da) | 1999-08-04 | 2005-01-24 | Agouron Pharma | Antipicornavirale forbindelser og sammensætninger, deres farmaceutiske anvendelser og materialer til deres syntese |
| PA8507801A1 (es) | 1999-12-03 | 2002-08-26 | Agouron Pharma | Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis |
| PE20011277A1 (es) | 2000-04-14 | 2002-01-07 | Agouron Pharma | Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis |
| JP2004503533A (ja) | 2000-06-14 | 2004-02-05 | アグロン・ファーマシュウティカルズ・インコーポレーテッド | 抗ピコルナウイルス化合物及び組成物、その医薬的使用、並びにその合成のための物質 |
| CN1309712C (zh) * | 2004-04-02 | 2007-04-11 | 中国科学院上海有机化学研究所 | Ag7088类化合物的关键中间体的前体及其合成方法 |
| EP4114384A1 (en) | 2020-03-06 | 2023-01-11 | Pfizer Inc. | Methods of inhibiting sars-cov-2 replication and treating coronavirus disease 2019 |
| CN115322130B (zh) * | 2022-08-02 | 2024-05-14 | 南京正济医药研究有限公司 | 制备(s)-2-(boc-氨基)-3-[(s)-2-氧代-3-吡咯烷基]丙酸甲酯 |
| CN115260074B (zh) * | 2022-08-02 | 2024-06-21 | 爱斯特(成都)生物制药股份有限公司 | 一种口服抗病毒药物Paxlovid中间体的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69733137T2 (de) * | 1996-05-14 | 2006-03-02 | Agouron Pharmaceuticals, Inc., San Diego | Inhibitoren von picornavirus 3c protease und verfahren zur herstellung und verwendung |
| CA2289541A1 (en) * | 1997-03-28 | 1998-10-08 | Peter S. Dragovich | Antipicornaviral compouds, compositions containing them, and methods for their use |
| US5962487A (en) * | 1997-12-16 | 1999-10-05 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds and methods for their use and preparation |
| EP1073672B1 (en) * | 1998-04-30 | 2003-08-27 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds, their preparation and use |
-
2000
- 2000-08-22 PE PE2000000854A patent/PE20010517A1/es not_active Application Discontinuation
- 2000-08-23 MX MXPA02001944A patent/MXPA02001944A/es active IP Right Grant
- 2000-08-23 CZ CZ2002632A patent/CZ2002632A3/cs unknown
- 2000-08-23 UY UY26307A patent/UY26307A1/es not_active Application Discontinuation
- 2000-08-23 BR BR0013306-0A patent/BR0013306A/pt not_active IP Right Cessation
- 2000-08-23 AU AU67971/00A patent/AU770221B2/en not_active Ceased
- 2000-08-23 PL PL00353997A patent/PL353997A1/xx not_active Application Discontinuation
- 2000-08-23 HU HU0203365A patent/HUP0203365A3/hu unknown
- 2000-08-23 EP EP00955831A patent/EP1206450A1/en not_active Withdrawn
- 2000-08-23 JP JP2001518419A patent/JP2003507453A/ja active Pending
- 2000-08-23 CA CA002376452A patent/CA2376452A1/en not_active Abandoned
- 2000-08-23 KR KR1020027002322A patent/KR20020046283A/ko not_active Ceased
- 2000-08-23 CN CNB008118779A patent/CN1168713C/zh not_active Expired - Fee Related
- 2000-08-23 IL IL14767400A patent/IL147674A0/xx unknown
- 2000-08-23 WO PCT/US2000/023033 patent/WO2001014329A1/en not_active Ceased
- 2000-08-23 HK HK03101461.5A patent/HK1049336B/zh not_active IP Right Cessation
- 2000-08-24 CO CO00063457A patent/CO5200782A1/es not_active Application Discontinuation
- 2000-08-24 AR ARP000104401A patent/AR025380A1/es unknown
- 2000-10-24 TW TW089117083A patent/TWI245040B/zh active
-
2002
- 2002-01-21 ZA ZA200200504A patent/ZA200200504B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6797100A (en) | 2001-03-19 |
| PE20010517A1 (es) | 2001-05-16 |
| CZ2002632A3 (cs) | 2003-04-16 |
| JP2003507453A (ja) | 2003-02-25 |
| KR20020046283A (ko) | 2002-06-20 |
| HK1049336A1 (en) | 2003-05-09 |
| HUP0203365A3 (en) | 2003-12-29 |
| BR0013306A (pt) | 2002-05-28 |
| HUP0203365A2 (hu) | 2003-02-28 |
| CA2376452A1 (en) | 2001-03-01 |
| ZA200200504B (en) | 2003-03-26 |
| CN1374947A (zh) | 2002-10-16 |
| EP1206450A1 (en) | 2002-05-22 |
| AU770221B2 (en) | 2004-02-19 |
| PL353997A1 (en) | 2003-12-15 |
| WO2001014329A1 (en) | 2001-03-01 |
| HK1049336B (zh) | 2005-05-20 |
| MXPA02001944A (es) | 2002-10-31 |
| UY26307A1 (es) | 2001-04-30 |
| TWI245040B (en) | 2005-12-11 |
| CO5200782A1 (es) | 2002-09-27 |
| AR025380A1 (es) | 2002-11-20 |
| IL147674A0 (en) | 2002-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1173174A (zh) | 取代的噁唑烷需钙蛋白酶和/或组织蛋白酶b抑制剂 | |
| CN101035790A (zh) | (1s,5s)-3-(5,6-二氯代吡啶-3-基)-3,6-二氮杂二环[3.2.0]庚烷苯磺酸盐 | |
| CN1168713C (zh) | 制备鼻病毒蛋白酶抑制剂的合成路线以及关键的中间体 | |
| CN1771234A (zh) | 吡咯并三嗪激酶抑制剂的制备方法 | |
| CN1798744A (zh) | 作为nmda/nr2b拮抗剂的3-氟-哌啶化合物 | |
| CN1934083A (zh) | 作为肾素抑制剂用于治疗高血压的5-氨基-4-羟基-7-(1h-吲哚基甲基)-8-甲基壬酰胺衍生物 | |
| CN1125575A (zh) | 粘附受体拮抗剂 | |
| CN1255498A (zh) | 生长激素促分泌剂的制备方法和中间体 | |
| CN1205704A (zh) | 2,7-取代的八氢-吡咯并[1,2-a]吡嗪衍生物 | |
| CN1025334C (zh) | 新的谷氨酸衍生物的制备方法 | |
| CN1337960A (zh) | 作为abeta原纤维形成抑制剂的哌啶和哌嗪衍生物 | |
| CN1753886A (zh) | 多元碱化合物的酸加成盐的制造方法 | |
| CN101068782A (zh) | 合成4-(3-磺酰基苯基)-哌啶类的方法 | |
| CN1900076A (zh) | 四氢原小檗碱类化合物及其制备方法和用途 | |
| CN1137891C (zh) | 生长激素促分泌素的制备方法 | |
| CN1083425C (zh) | 由环氧化物制备顺式-1-氨基-2-链烷醇的区域专一性方法 | |
| CN1130905A (zh) | Hiv蛋白酶抑制剂的制备方法 | |
| CN1252402A (zh) | Hiv蛋白酶抑制剂的制备方法 | |
| CN101065361A (zh) | 具有取代己内酰胺环的bengamides,其制备方法,含有它们的组合物与其用途 | |
| CN1117729A (zh) | 吗啉衍生物 | |
| CN1041731C (zh) | 吡啶并[1,2,3—d,e][1,3,4]苯并噁二嗪衍生物 | |
| CN1253458C (zh) | 物质gm-95的制备方法 | |
| CN1269798A (zh) | 立体异构吲哚化合物、其制备方法及用途 | |
| US6774243B2 (en) | Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates | |
| CN1486298A (zh) | 兴奋性氨基酸前体药物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |